肺癌肺段切除术质量的全国趋势
该研究利用美国国家癌症数据库分析2004至2018年临床I至IIA期非小细胞肺癌肺段切除术的质量趋势。肺段切除术占比从2004年3.3%升至2018年6.1%,仅12.6%患者符合全部质量指标,学术机构依从性更高(OR 1.56),依从全部指标与生存改善相关(HR 0.67)。
要点
- 肺段切除术占比从2004年3.3%增至2018年6.1%(P<.001)
- 仅12.6%的肺段切除术患者符合全部质量指标
- 学术机构依从全部指标的OR为1.56(95%CI 1.14-2.15)
核心结论
- 肺段切除术作为非小细胞肺癌的有效肿瘤学选择日益确立,保持高质量很重要。
- 本研究显示需要持续改进肺段切除术的质量。
研究设计与样本
- 使用美国国家癌症数据库识别2004至2018年间接受手术治疗的临床I至IIA期非小细胞肺癌患者。
- 研究纳入249391例患者,其中4.4%(n=11006)接受肺段切除术。
- 基于肺段切除术对全部质量指标复合依从性进行倾向性评分匹配,采用Cox模型和Kaplan-Meier生存估计评估生存。
主要发现
- 肺段切除术年度占比从2004年3.3%增至2018年6.1%(P<.001)。
- 2004至2018年间接受肺段切除术的患者中,12.6%(n=1385)依从全部质量指标。
- 学术机构比非学术机构更可能依从全部指标(OR 1.56,95%CI 1.14-2.15;非学术机构为参照,P<.001)。
- 依从全部指标与生存改善相关(HR 0.67,95%CI 0.56-0.79)。
关键数值与推荐
- 质量指标包括:采样10个或以上淋巴结(2014年美国癌症委员会指南)、阴性(R0)切除边缘、肿瘤大小2 cm或以下。
- 依从全部指标定义为符合上述所有措施。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Segmentectomy has become an accepted procedure for the treatment of non-small cell lung cancer. Adequate lymph node sampling, sufficient margins, and proper tumor size selection are factors vital for achieving outcomes comparable to lobectomy. Previous studies have demonstrated poor adherence to lymph node sampling guidelines. However, national trends in the quality of segmentectomy and implications on survival are unknown. METHODS: The National Cancer Database was used to identify patients with clinical stage I to IIA non-small cell lung cancer surgically treated between 2004 and 2018. Facility-level trends in extent of resection and segmentectomy odds of adherence to (1) 2014 Commission on Cancer guidelines of sampling 10 or more lymph nodes, (2) negative (R0) resection margins, and (3) tumor size 2 cm or less were determined. Propensity score matching was based on segmentectomy adherence to (4) a composite of all measures, and survival was evaluated with Cox models and Kaplan-Meier survival estimates. RESULTS: The study included 249,391 patients with 4.4% (n = 11,006) treated with segmentectomy. The proportion of segmentectomies performed annually increased from 3.3% in 2004 to 6.1% in 2018 (P < .001). Overall, 12.6% (n = 1385) of patients who underwent segmentectomy between 2004 and 2018 were adherent to all measures, and adherence was more likely at academic programs (odds ratio, 1.56; 95% confidence interval, 1.14-2.15) than nonacademic programs (P < .001, reference). Adherence to all measures was associated with improved survival (hazard ratio, 0.67; 95% confidence interval, 0.56-0.79). CONCLUSIONS: As segmentectomy is increasingly established as a valid oncological option for the treatment of non-small cell lung cancer, it is important that quality remains high. This study demonstrates that continued improvement is needed.
引用
- Logan CD, Jacobs RC, Feinglass J, et al. National trends in the quality of segmentectomy for lung cancer. J Thorac Cardiovasc Surg. 2022. PMID: 36088143. doi:10.1016/j.jtcvs.2022.05.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。